Table 3 Diagnosis, treatment and evaluation (n = 174)
N | (%) | x | (sd) | ||
|---|---|---|---|---|---|
Recurrent injury | No | 138 | (80) | ||
Yes | 35 | (20) | |||
Missing | 1 | ||||
Co-morbidity | No | 158 | (91) | ||
Yes | 16 | (9) | |||
Duration complaint | Days | 174 | 7.1 | (7.1) | |
Normal recovery | No | 30 | (17) | ||
Yes | 142 | (82) | |||
Unknown | 1 | (0.5) | |||
Missing | 1 | (0.5) | |||
Phase of recovery | Phase 1 | 74 | (43) | ||
Phase 2 | 79 | (45) | |||
Phase 3 | 14 | (8) | |||
Phase 4 | 7 | (4) | |||
Function Score | Intake (assessment) | 174 | 28.4 | (17.5) | |
(max of 100 points) | End (evaluation) | 87.4 | (13.4) | ||
Treatment sessions | Number of sessions | 174 | 5.2 | (2.9) |